Full FDA Approval of Keryx's (KERX) Zerenex Expected - Roth Capital
Tweet Send to a Friend
Roth Capital affirms Keryx Biopharma (Nasdaq; KERX) at Buy into the September 7th PDUFA date for Zerenex.Analyst Joseph Pantginis sees ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE